Category: Pα+ - Psychedelic Alpha

Read more about the article Pα+ Psychedelic Bulletin #193: VA Secretary on Psychedelics; Preprint Challenges Replicability of Psilocybin’s Persistent Effects in Mice; Market Mayhem and Agency Shake-Ups

Pα+ Psychedelic Bulletin #193: VA Secretary on Psychedelics; Preprint Challenges Replicability of Psilocybin’s Persistent Effects in Mice; Market Mayhem and Agency Shake-Ups

Post published:April 11, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape

Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape

Post published:April 9, 2025
Post category:Analysis News Pα+

Read more about the article March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms

March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms

Post published:April 7, 2025
Post category:Analysis News Pα+

Read more about the article Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

Post published:March 31, 2025
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #192: Psychedelic Safety; Compass’ Lacklustre Long-Term Data; LSD Microdosing No Better than Placebo in ADHD

Pα+ Psychedelic Bulletin #192: Psychedelic Safety; Compass’ Lacklustre Long-Term Data; LSD Microdosing No Better than Placebo in ADHD

Post published:March 28, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article February 2025 Psychedelic Patent Update: Terran Secures New Overlapping IP; Porta Sophia Becomes USPTO Information Source

February 2025 Psychedelic Patent Update: Terran Secures New Overlapping IP; Porta Sophia Becomes USPTO Information Source

Post published:March 27, 2025
Post category:Psychedelic Patent Analysis Pα+

Read more about the article Pα+ Psychedelic Bulletin #191: Psychedelics at SXSW; Swiss Study Finds No Impact of Psilocybin on Alcohol Use Disorder

Pα+ Psychedelic Bulletin #191: Psychedelics at SXSW; Swiss Study Finds No Impact of Psilocybin on Alcohol Use Disorder

Post published:March 17, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article Behind the Scenes of the “Psychedelic Renaissance” at SXSW 2025

Behind the Scenes of the “Psychedelic Renaissance” at SXSW 2025

Post published:March 14, 2025
Post category:Analysis News Pα+

Read more about the article Inside the World’s Most Active Psychedelic Therapy Site: A Conversation with Sunstone Therapies

Inside the World’s Most Active Psychedelic Therapy Site: A Conversation with Sunstone Therapies

Post published:March 12, 2025
Post category:Interviews Pα+

Read more about the article Pα+ Psychedelic Bulletin #190: ‘Europe’s Most Feared Investor’ Teams Up with Musk Associate to Fund Lykos Therapeutics

Pα+ Psychedelic Bulletin #190: ‘Europe’s Most Feared Investor’ Teams Up with Musk Associate to Fund Lykos Therapeutics

Post published:March 6, 2025
Post category:Psychedelic Bulletin Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.